Intrinsiqs

Is Orchestra BioMed Holdings, Inc. overvalued?

Orchestra BioMed Holdings, Inc. (OBIO) — key valuation metrics and fundamentals.

No verdict
Price
$5.89
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$352.7M
Dividend yield
0.0%
Return on equity
-125.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares OBIO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.